Found: 14
Select item for more details and to access through your institution.
A low dose of RBD and TLR7/8 agonist displayed on influenza virosome particles protects rhesus macaque against SARS-CoV-2 challenge.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-31818-y
- By:
- Publication type:
- Article
Synthetic Human Chorionic Gonadotropin-Related Oligopeptides Impair Early Innate Immune Responses to Listeria monocytogenes in Mice.
- Published in:
- Journal of Infectious Diseases, 2010, v. 201, n. 7, p. 1072, doi. 10.1086/651134
- By:
- Publication type:
- Article
Survival and Functionality of Human Induced Pluripotent Stem Cell-Derived Oligodendrocytes in a Nonhuman Primate Model for Multiple Sclerosis.
- Published in:
- Stem Cells Translational Medicine, 2016, v. 5, n. 11, p. 1550, doi. 10.5966/sctm.2016-0024
- By:
- Publication type:
- Article
The common marmoset (Callithrix jacchus): a relevant preclinical model of human (auto)immune-mediated inflammatory disease of the brain.
- Published in:
- Primate Biology, 2016, n. 2, p. 9, doi. 10.5194/pb-3-9-2016
- By:
- Publication type:
- Article
Axonal response of mitochondria to demyelination and complex IV activity within demyelinated axons in experimental models of multiple sclerosis.
- Published in:
- Neuropathology & Applied Neurobiology, 2023, v. 49, n. 1, p. 1, doi. 10.1111/nan.12851
- By:
- Publication type:
- Article
Reverse Translation for Assessment of Confidence in Animal Models of Multiple Sclerosis for Drug Discovery.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 103, n. 2, p. 262, doi. 10.1002/cpt.801
- By:
- Publication type:
- Article
A B Cell-Driven Autoimmune Pathway Leading to Pathological Hallmarks of Progressive Multiple Sclerosis in the Marmoset Experimental Autoimmune Encephalomyelitis Model.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.00804
- By:
- Publication type:
- Article
Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis.
- Published in:
- Journal of NeuroImmune Pharmacology, 2016, v. 11, n. 1, p. 73, doi. 10.1007/s11481-015-9629-6
- By:
- Publication type:
- Article
Induction of Experimental Autoimmune Encephalomyelitis With Recombinant Human Myelin Oligodendrocyte Glycoprotein in Incomplete Freund’s Adjuvant in Three Non-human Primate Species.
- Published in:
- Journal of NeuroImmune Pharmacology, 2013, v. 8, n. 5, p. 1251, doi. 10.1007/s11481-013-9487-z
- By:
- Publication type:
- Article
Effects of Early IL-17A Neutralization on Disease Induction in a Primate Model of Experimental Autoimmune Encephalomyelitis.
- Published in:
- Journal of NeuroImmune Pharmacology, 2011, v. 6, n. 3, p. 341, doi. 10.1007/s11481-010-9238-3
- By:
- Publication type:
- Article
Experimental Autoimmune Encephalomyelitis in the Common Marmoset, a Bridge Between Rodent EAE and Multiple Sclerosis for Immunotherapy Development.
- Published in:
- Journal of NeuroImmune Pharmacology, 2010, v. 5, n. 2, p. 220, doi. 10.1007/s11481-009-9178-y
- By:
- Publication type:
- Article
Pin1 levels are downregulated during ER stress in human neuroblastoma cells.
- Published in:
- Neurogenetics, 2007, v. 8, n. 1, p. 21, doi. 10.1007/s10048-006-0060-2
- By:
- Publication type:
- Article
The primate EAE model points at EBV-infected B cells as a preferential therapy target in multiple sclerosis.
- Published in:
- Frontiers in Immunology, 2013, v. 4, p. 1, doi. 10.3389/fimmu.2013.00145
- By:
- Publication type:
- Article
Severe oxidative stress in an acute inflammatory demyelinating model in the rhesus monkey.
- Published in:
- PLoS ONE, 2017, v. 12, n. 11, p. 1, doi. 10.1371/journal.pone.0188013
- By:
- Publication type:
- Article